The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Changes In Market Value Are Expected For The Artificial Intelligence (AI) In Respiratory Diseases Market Over The 2026–2030 Period?
The artificial intelligence (AI) in respiratory diseases market has shown sustained expansion in recent times. Forecasts indicate that it will increase from $7.98 billion in 2025 to $8.38 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.9%. Historically, this growth stemmed from the escalating prevalence of respiratory conditions, a rise in the application of CT and MRI imaging, the ongoing digitalization of healthcare documentation, the initial embrace of AI-powered diagnostics, and the broadening of hospital diagnostic capacities.
The artificial intelligence (AI) in respiratory diseases market size is anticipated to demonstrate robust expansion in the upcoming years. It is projected to achieve a valuation of $10.19 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.0%. This anticipated growth can be ascribed to a rising need for personalized respiratory care, the increasing integration of AI with clinical decision support systems, the wider adoption of remote monitoring for chronic respiratory patients, a heightened emphasis on preventive pulmonology, and advancements in medical imaging AI. Notable trends during the forecast period include a greater application of AI-based imaging analysis, the growing implementation of predictive disease progression models, an expanding integration of AI in pulmonary diagnostics, the proliferation of remote respiratory monitoring solutions, and an enhanced commitment to early disease detection.
Access Your Free Sample Report For In-Depth Market Analysis:
What Key Factors Are Shaping The Artificial Intelligence (AI) In Respiratory Diseases Market Landscape?
When considering the progression of the respiratory disease market, environmental pollution is characterized by the introduction of any material or energy form into the environment at a rate faster than it can be safely assimilated or stored. Artificial intelligence (AI) applied to respiratory diseases possesses the capability to substantially diminish environmental pollution’s adverse effects on respiratory well-being through real-time surveillance, individualized risk evaluations, well-informed choices, and innovative strategies for both people and wider communities. As an illustration, in November 2024, the Japan-based annual scientific evaluation, the Global Carbon Budget, indicated that fossil carbon dioxide emissions reached 37.4 billion tonnes, representing a 0.8% rise from the prior year. Thus, the escalating environmental pollution serves as a significant impetus for the expansion of artificial intelligence (AI) in the respiratory disease market.
How Is The Artificial Intelligence (AI) In Respiratory Diseases Market Segmented Across Different Segment Categories?
The artificial intelligence (AI) in respiratory diseases market covered in this report is segmented –
1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)
2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection
3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging
2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT
3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments
What Market Trends Are Affecting The Artificial Intelligence (AI) In Respiratory Diseases Market?
Leading companies active in artificial intelligence (AI) in the respiratory diseases market are creating advanced products like N-Tidal devices for monitoring patients’ tidal breathing. The N-Tidal device quantifies the air volume exchanged during normal respiration and yields essential data regarding lung function. For example, in August 2023, TidalSense, a UK-based respiratory technology company, introduced N-Tidal, which is a regulated AI technology for the diagnosis and management of chronic obstructive pulmonary disease (COPD). This technology integrates N-Tidal’s CO2 sensor data with an artificial intelligence platform to measure shifts in lung function, aiming to enhance the diagnosis and management of this respiratory ailment. Clinical investigations have confirmed the technology’s notable accuracy, and it is projected to revolutionize the diagnostic approach for respiratory conditions. This launch represents a key progression in applying AI for respiratory disease assessment, presenting a more convenient and effective substitute for current diagnostic examinations.
Which Organizations Play A Role In The Artificial Intelligence (AI) In Respiratory Diseases Market Landscape?
Major companies operating in the artificial intelligence (AI) in respiratory diseases market are Siemens Healthineers, Philips Healthcare, GE Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Swaasa AI, VIDA Diagnostics Inc., Enlitic, Thirona B.V., ArtiQ, Icometrix, Aidence, Arterys, PneumoWave Ltd
Get The Full Artificial Intelligence (AI) In Respiratory Diseases Market Report:
Which Region Represents The Largest Share Of The Artificial Intelligence (AI) In Respiratory Diseases Market?
North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Artificial Intelligence (AI) In Respiratory Diseases Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Respiratory Diseases Market 2026, By The Business Research Company
Artificial Intelligence Ai In Animal Health Market Report 2026
Artificial Intelligence In Healthcare Diagnosis Market Report 2026
Ai In Medical Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-medical-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model